HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Grant Dorsey Selected Research

Therapeutics

8/2023Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda.
1/2023Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention.
10/2022East Africa International Center of Excellence for Malaria Research: Impact on Malaria Policy in Uganda.
11/2020Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women.
6/2020The impact of gravidity, symptomatology and timing of infection on placental malaria.
1/2020The Impact of Control Interventions on Malaria Burden in Young Children in a Historically High-Transmission District of Uganda: A Pooled Analysis of Cohort Studies from 2007 to 2018.
1/2020The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
1/2020Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data.
12/2019Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention.
1/2019Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Grant Dorsey Research Topics

Disease

200Malaria
04/2024 - 12/2002
42Infections
03/2024 - 12/2002
35Falciparum Malaria (Plasmodium falciparum Malaria)
01/2020 - 02/2003
28Parasitemia
11/2021 - 05/2006
12Fever (Fevers)
03/2024 - 01/2007
8Pregnancy Complications
01/2020 - 03/2016
8HIV Infections (HIV Infection)
12/2017 - 01/2006
6Reinfection
01/2020 - 02/2003
4Acute malaria
10/2020 - 09/2013
4Anemia
08/2016 - 07/2010
3Birth Weight (Birth Weights)
04/2024 - 01/2020
3Malnutrition (Nutritional Deficiencies)
01/2023 - 06/2011
3Sickle Cell Trait
01/2023 - 08/2008
3Stillbirth
01/2022 - 12/2017
3Premature Birth (Birth, Premature)
01/2019 - 12/2017
3Glucosephosphate Dehydrogenase Deficiency
01/2018 - 08/2008
3Pruritus (Itching)
11/2012 - 02/2007
3Vomiting
08/2012 - 11/2009
2Growth Disorders
01/2023 - 03/2012
2Communicable Diseases (Infectious Diseases)
02/2021 - 01/2021
2Measles
01/2021 - 06/2008
2Diarrhea
01/2015 - 07/2009
2Neutropenia
10/2011 - 04/2008

Drug/Important Bio-Agent (IBA)

57Antimalarials (Antimalarial Agents)IBA
04/2024 - 02/2003
46artenimol (dihydroartemisinin)IBA
04/2024 - 05/2007
46piperaquineIBA
04/2024 - 05/2007
38pyrimethamine drug combination fanasil (Fansidar)FDA Link
04/2024 - 12/2002
36Lumefantrine Drug Combination Artemether (Coartem)FDA Link
03/2024 - 05/2006
34artemisinin (artemisinine)IBA
08/2023 - 07/2005
27InsecticidesIBA
03/2024 - 01/2012
27Amodiaquine (Camoquin)FDA Link
01/2020 - 12/2002
19ArtesunateIBA
01/2020 - 12/2002
17Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2023 - 09/2006
12insulin receptor-related receptor (IRR)IBA
01/2022 - 12/2004
11Chloroquine (Aralen)FDA LinkGeneric
07/2014 - 02/2003
10AntigensIBA
10/2020 - 07/2011
8CytokinesIBA
08/2020 - 01/2014
7Pyrethrins (Pyrethroids)FDA Link
01/2023 - 11/2016
7Folic Acid AntagonistsIBA
12/2014 - 02/2003
6Interleukin-10 (Interleukin 10)IBA
09/2023 - 01/2014
6efavirenz (Sustiva)FDA Link
01/2023 - 11/2012
6Hemoglobins (Hemoglobin)IBA
01/2020 - 05/2007
6LopinavirFDA Link
01/2018 - 11/2012
5Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 02/2011
5Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2007
5Ritonavir (Norvir)FDA Link
01/2018 - 11/2012
4CarbamatesIBA
03/2024 - 01/2012
4bendiocarbIBA
03/2024 - 01/2012
4Piperonyl ButoxideFDA Link
01/2023 - 06/2019
4AntibodiesIBA
01/2022 - 07/2011
4Merozoite Surface Protein 1 (MSA1)IBA
06/2015 - 02/2003
4Indicators and Reagents (Reagents)IBA
01/2015 - 09/2009
4Reverse Transcriptase InhibitorsIBA
08/2014 - 11/2012
3OrganophosphatesIBA
03/2024 - 01/2022
3LumefantrineFDA Link
01/2015 - 08/2009
3SulfamethoxazoleFDA LinkGeneric
12/2012 - 11/2009
3Trimethoprim (Proloprim)FDA LinkGeneric
12/2012 - 11/2009
3Membrane Proteins (Integral Membrane Proteins)IBA
07/2011 - 12/2002
3Dihydropteroate Synthase (Dihydropteroate Synthetase)IBA
05/2010 - 12/2004
2pirimiphos methyl (Aktel)IBA
03/2024 - 01/2020
2clothianidinIBA
03/2024 - 01/2022
2hemoglobin AAIBA
01/2023 - 11/2021
2Fc Receptors (Fc Receptor)IBA
01/2023 - 10/2020
2HLA-C Antigens (HLA-C)IBA
02/2021 - 01/2021
2LigandsIBA
02/2021 - 01/2021
2InterferonsIBA
08/2020 - 01/2016
2Immunoglobulin G (IgG)IBA
01/2020 - 01/2012
22- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA
01/2019 - 01/2015
2Protease Inhibitors (Protease Inhibitor)IBA
01/2018 - 04/2013
2Interleukin-2 (IL2)IBA
12/2017 - 01/2016
2Sickle HemoglobinIBA
11/2017 - 12/2004
2glucose-6-phosphate dehydrogenase A-IBA
11/2017 - 12/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 12/2004
2Biomarkers (Surrogate Marker)IBA
08/2015 - 01/2012
2Nevirapine (Viramune)FDA Link
03/2015 - 08/2014
2DNA (Deoxyribonucleic Acid)IBA
09/2013 - 10/2010
2Quinine (Quinson)FDA Link
07/2013 - 07/2009
2Pyrimethamine (Daraprim)FDA Link
01/2012 - 11/2004
2ORALIT (ORS)IBA
01/2012 - 07/2009
2RNA (Ribonucleic Acid)IBA
07/2010 - 06/2008
2Folic Acid (Vitamin M)FDA LinkGeneric
06/2010 - 11/2006
2Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
05/2010 - 09/2006
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2008 - 06/2007
2Histidine (L-Histidine)FDA Link
02/2008 - 06/2007
2EnzymesIBA
12/2007 - 08/2006
1Dihydrotachysterol (AT 10)IBA
08/2023
1ArtemisininsIBA
08/2023
1Histones (Histone)IBA
01/2023
1Leukocyte Immunoglobulin-like Receptor B1IBA
01/2023
1A 17 (A-17)IBA
01/2023
1decamethrin (deltamethrin)IBA
01/2022

Therapy/Procedure

70Therapeutics
08/2023 - 12/2002
24Chemoprevention
04/2024 - 08/2003
10Insecticide-Treated Bednets
01/2022 - 10/2007
7Aftercare (After-Treatment)
01/2020 - 05/2006
6Art Therapy
01/2019 - 04/2012
2Mass Drug Administration
11/2022 - 02/2017
2Microspheres (Microsphere)
10/2016 - 08/2014
2Retreatment
11/2009 - 11/2004
1Ambulatory Care (Outpatient Care)
06/2021